Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Japanese study supports in vivo antitumor activity of Golgi-disrupting agent

Jan. 12, 2012

Adherex continues enrollment in phase II eniluracil regimen study

Jan. 11, 2012

BKM-120 assessed as monotherapy and in combination regimens in metastatic breast cancer

Jan. 11, 2012

Phase II trial investigates effects of axitinib in metastatic melanoma

Jan. 11, 2012

Novel estrogen receptor-alpha modulators prepared by Aragon Pharmaceuticals

Jan. 10, 2012

AstraZeneca patents new protein kinase inhibitors

Jan. 10, 2012

New Evestra progesterone receptor inhibitor shows potential as breast cancer therapy

Jan. 10, 2012

Phase I/II data presented on SAR-245408-based combination regimens in metastatic breast cancer

Jan. 10, 2012

Ongoing phase I/II trial assesses combinations of letrozole with SAR-245408 and SAR-245409

Jan. 10, 2012

Novel approach leads to discovery of NME that prevents tumor invasion

Jan. 10, 2012

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...